Literature DB >> 4029247

Effects of transdermal scopolamine upon psychological test performance at sea.

A C Parrott, R Jones.   

Abstract

The effects of transdermal scopolamine upon objective psychological performance assessments and self reports of feeling states, were investigated with volunteer subjects at sea. Scopolamine and placebo patches were administered on consecutive days in a counterbalanced order. Psychological performance was assessed 24 h following each transdermal patch. Choice reaction time and code substitution performance levels were not significantly changed, but letter cancellation errors were significantly more frequent following transdermal scopolamine. Transdermal scopolamine caused significantly more reports of dry mouth. More subjects were also unable to undertake the performance tests following scopolamine than placebo, due to difficulties in focusing on the test materials. However despite deleterious side effects with some personnel, others responded positively to the scopolamine patch. As noted by other workers, responses to the transdermal scopolamine patch seem to be quite variable.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029247     DOI: 10.1007/bf00544360

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Relative efficacy of the proposed Space Shuttle antimotion sickness medications.

Authors:  J R Hordinsky; E Schwartz; J Beier; J Martin; G Aust
Journal:  Acta Astronaut       Date:  1982 Jun-Jul       Impact factor: 2.413

2.  Side effects of remedies for motion sickness.

Authors:  E M GLASER
Journal:  Int Rec Med Gen Pract Clin       Date:  1955-01

3.  Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods.

Authors:  J J Brand; W L Perry
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

4.  Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.

Authors:  J L Homick; R L Kohl; M F Reschke; J Degioanni; N M Cintron-Trevino
Journal:  Aviat Space Environ Med       Date:  1983-11

5.  Prevention of experimental motion sickness by scopolamine absorbed through the skin.

Authors:  A Graybiel; J Knepton; J Shaw
Journal:  Aviat Space Environ Med       Date:  1976-10

6.  Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administration.

Authors:  A Graybiel; D B Cramer; C D Wood
Journal:  Aviat Space Environ Med       Date:  1982-08

7.  Scopolamine-induced muscarinic supersensitivity in normal man: changes in sleep.

Authors:  N Sitaram; A M Moore; J C Gillin
Journal:  Psychiatry Res       Date:  1979-07       Impact factor: 3.222

8.  Nomifensine, clobazam and HOE 8476: effects on aspects of psychomotor performance and cognitive ability.

Authors:  A C Parrott; I Hindmarch; P D Stonier
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

9.  Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task.

Authors:  K Wesnes; D M Warburton
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

10.  Transdermal scopolamine in the prevention of motion sickness at sea.

Authors:  N M Price; L G Schmitt; J McGuire; J E Shaw; G Trobough
Journal:  Clin Pharmacol Ther       Date:  1981-03       Impact factor: 6.875

View more
  3 in total

Review 1.  Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.

Authors:  Zohar Nachum; Avi Shupak; Carlos R Gordon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.

Authors:  A C Parrott
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects.

Authors:  A C Parrott; K Wesnes
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.